- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT02248194
Tactile Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding (TEA)
Tactile Versus Hysteroscopic Electrosurgical Ablation in Cases of Dysfunctional Uterine Bleeding
Abnormal uterine bleeding (AUB) is any alteration in the pattern or volume of menstrual blood flow and heavy menstrual bleeding affects up to 30% of women at some time during their reproductive years. Abnormal menstruation can be due to conditions such as pregnancy complication uterine fibroids and adenomyosis, but in a large proportion of cases, the etiology is unclear, a condition generally referred to as dysfunctional uterine bleeding (DUB). Treatment options for DUB include symptomatic medical treatment or surgery, traditionally hysterectomy.
Hysteroscopically guided endometrial ablation methods have been shown to be effective and safe alternatives to hysterectomy for management of DUB. These methods require particular skills and experience and a long learning curve to be performed effectively and safely.
Through the past three decades DUB patients in Assiut university hospital were treated with either electrosurgical ablation or hysterectomy. When faced with hysteroscopic challenges during transcervical resection of the endometrium or rollerball coagulation, we used to shift to thermal balloon as backup method . However, expensive uterine balloon could not infrequently be afforded because of financial constrains and limited health resources . Therefore, another method was used as backup for hysteroscopic failures. It was first tried via insulating the conventional double-ended uterine curette then through a specially designed tactile electrosurgical ablation (TEA) probe.The technique of TEA is largely similar to the dilatation and curettage procedure both principally and practically. Hence, the basic requirements for its performance are the general awareness with electrosurgical principles and adequate experience in performing dilatation and curettage. TEA is done by specially designed tactile diathermy probe that carried the job of electrosurgical ablation without hysteroscopy or distension media first in an experimental session that clearly clarified the reproducibility of the depth of thermal damage and safety of the tactile electrosurgical ablator . Thereafter, TEA was successfully performed with satisfactory short and medium term outcomes for ten cases with DUB during an active, relentless bleeding attack. TEA is done under laparoscopic monitoring.
The aim of the present work is to present TEA as a simple, inexpensive, novel backup approach for treatment of DUB.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Fase 2
Kontakter og lokationer
Studiesteder
-
-
-
Assiut, Egypten
- Woman's Health Hospital-Assiut University.
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Patients with dysfunctional uterine bleeding aged between 40 to 50 years
- Unsuccessful medical treatment.
- No intrauterine abnormalities.
- Endometrial biopsy negative for atypia and cancer.
- follicle stimulating hormone level not exceeds 30 mills-International unit
- Family complete
- Patients who are not candidate for hysterectomy because of medical or surgical risks.
Exclusion Criteria:
- Coexisting gynecological pathology (e.g. uterovaginal prolapsed, ovarian pathology, pelvic inflammatory disease, cervical atypia).
- Endometrial hyperplasia with atypia and cancer..
- History or evidence of malignancy.
- Hyperplasia in the endometrial biopsy.
- Uterine size more than 12 weeks in size.
- Women with caesarean or myomectomy scar
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
---|---|
Eksperimentel: Group 1"Tactile electrosurgical ablation"
Endometrial ablation will be done by Tactile electrosurgical ablation probe.
|
Andre navne:
|
Aktiv komparator: Group 2 "Hysteroscopic endometrial ablation"
Hysteroscopic endometrial ablation will be done by trans-cervical resection of endometrium.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Satisfaction with the treatment at 12 month follow up
Tidsramme: 12 moth
|
Satisfaction with the treatment will be measured at 1 year post procedure on 3-point scale-very satisfied, satisfied, and not satisfied.
|
12 moth
|
Change in menstrual status.
Tidsramme: At 3, 6, 9, and12 months pot operatve.
|
Menstrual status will be reported as
|
At 3, 6, 9, and12 months pot operatve.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Acceptability of treatment
Tidsramme: 4 weeks
|
Acceptability of the procedure will be assessed in 3- point scale as cure or acceptable improvement in symptoms, treatment acceptable and would recommend treatment to others or not acceptable
|
4 weeks
|
Changes in health related quality of life
Tidsramme: At 3, 6, 9, and 12 months post operative.
|
Health-related quality of life parameters will be completed using
|
At 3, 6, 9, and 12 months post operative.
|
Difference in operative time between the two groups in minutes.
Tidsramme: 0-60 minutes
|
Difference in operative time is calculated using a stop watch.The zero minute is the time of starting the procedure.
The stop watch is on at the zero minute then sopped at the end of the procedure.time of anesthesia is not included.
|
0-60 minutes
|
Reporting of any intro-operative complications.
Tidsramme: 0-60 minutes.
|
Intro-operative complications includes
|
0-60 minutes.
|
Reporting of any technical complications.
Tidsramme: 0-60 minutes
|
Technical complications for transcervical resection of the endometrium (TCRE) includes
Technical complications for tactile electrosurgical ablation (TEA) includes
|
0-60 minutes
|
Difference in post-operative pain score using visual analogue scale between the two groups.
Tidsramme: 4 hours.
|
Difference in post-operative pain score using visual analogue scale from 1-10.
|
4 hours.
|
Time needed for post operative recovery (days) of pain, vaginal bleeding, vaginal discharge, till full recovery and till return to work.
Tidsramme: 28 days post operative
|
28 days post operative
|
|
Length of hospital stay in days
Tidsramme: up to 2 days
|
Length of hospital stay in days is calculated from the day of operation till day of discharge.
|
up to 2 days
|
Difference in the cost of the two surgical procedure.
Tidsramme: up to one hour.
|
Direct cost of the surgical procedure itself is calculated.The cost of the TCRE procedure will include the cost paid for the hysteroscopic unit and the cost of glycine used as distension media.The cost of the TEA procedure will include the cost of laparoscopy, the cost of TEA probe, and the cost of diagnostic hysteroscopy.
The cost of the investigations, anesthesia, pre and post operative treatments will be excluded from analysis as they are the same for both groups.
|
up to one hour.
|
Samarbejdspartnere og efterforskere
Sponsor
Samarbejdspartnere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Tactile ablation
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Dysfunction Uterine Bleeding
-
Stimdia Medical, Inc.AfsluttetVentilator-induceret diaphragmatic dysfunction (VIDD)Irland, Tjekkiet
-
Universitätsmedizin MannheimAfsluttetPerkutan koronar intervention (PCI) | Arteriel lukkeanordning | Adgang Site Bleeding | Uønskede hjertehændelserTyskland
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...RekrutteringPædiatrisk Sepsis-induceret Multiple Organ Dysfunction SyndromeForenede Stater
-
University of WaterlooAfsluttetMeibomian Gland Dysfunction (MGD)Canada
-
Nationwide Children's HospitalEunice Kennedy Shriver National Institute of Child Health and Human Development...RekrutteringPædiatrisk Sepsis-induceret Multiple Organ Dysfunction Syndrome (MODS)Forenede Stater
-
Grand Valley State UniversityTilmelding efter invitationMetabolic Associated-dysfunction Steatotic Lever Disease (MASLD) | Metabolic Associated-dysfunction Steatohepatitis (MASH)Forenede Stater
-
Singapore National Eye CentreNational University, SingaporeAfsluttet
-
Johnson & Johnson Surgical Vision, Inc.AfsluttetGrå stær | Meibomian Gland Dysfunction (MGD)Forenede Stater
-
Azura OphthalmicsThe University of New South WalesAfsluttetMeibomian Gland Dysfunction (MGD) | Kontaktlinsebesvær (CLD)Australien
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)AfsluttetUterin Corpus Leiomyosarcoma | Stadie IIA uterin sarkom | Stadie IIB uterin sarkom | Stadium IIIA Uterin Sarkom | Stadium IIIB Uterin Sarkom | Stadie IIIC Uterin Sarkom | Stadium IVA livmodersarkom | Stadium IVB livmodersarkom | Stadium IA uterin sarkom | Stadium IB uterin sarkom | Stadium IC Uterin SarkomForenede Stater
Kliniske forsøg med Hysteroscopic endometrial ablation
-
Birmingham Women's NHS Foundation TrustUkendt
-
Minerva Surgical, Inc.AfsluttetMenorragi på grund af godartede årsagerMexico
-
Minerva Surgical, Inc.AfsluttetMenorragi på grund af godartede årsagerCanada
-
Minerva Surgical, Inc.AfsluttetMenorrhagiaForenede Stater, Canada, Mexico
-
Minerva Surgical, Inc.AfsluttetMenorragi på grund af godartede årsagerUngarn
-
Cairo UniversityAfsluttet
-
Mansoura UniversityUkendtInfertilitet | Polycystisk ovariesyndromEgypten
-
Weill Medical College of Cornell UniversityAfsluttet
-
The First Affiliated Hospital of Zhengzhou UniversityUkendt
-
Benha UniversityUkendt